• Sodium Phosphate Dibasic for Assay Buffers

  2026-08-23

  Sodium phosphate dibasic, or Na2HPO4, is a water-soluble phosphate salt used to support pH control in biochemical and molecular biology workflows. Product information reports a molecular weight of 141.96 and 98.00% purity, while aquatic-toxicity literature shows why assay pH and solvent choice must be controlled independently.

• Antipyrine in BBB Assay Decision-Making

  2026-08-22

  Antipyrine can serve as a chemically well-characterized reference in permeability, pharmacokinetic studies, and pain research. This guide develops an evidence-aware workflow for separating barrier transport, recovery loss, and lysosomal trapping without overstating what current BBB models prove.

• Anlotinib hydrochloride: Anti-Angiogenic Workflows

  2026-08-22

  Build more informative angiogenesis assays with a multi-target tyrosine kinase inhibitor that connects endothelial migration, tube formation, receptor phosphorylation, and ERK pathway readouts. This guide translates published findings into practical workflows, comparison strategies, and troubleshooting decisions for cancer research.

• 7-AAD Cell Viability Assay Kit for CAR-T

  2026-08-21

  The 7-AAD Cell Viability Assay Kit adds a membrane-integrity endpoint to CD38 CAR-T studies, helping distinguish cytotoxicity from fratricide and handling damage. Learn how this 7-amino actinomycin D assay fits into multiplex flow cytometry and microscopy workflows without overstating what viability data can prove.

• Optimizing hiPSC-Derived Platelet Production

  2026-08-20

  A 2026 study presents a systematically optimized embryoid-body protocol for producing functional platelets from human induced pluripotent stem cells. By combining higher starting cell input, human platelet lysate, and small-molecule control of differentiation and megakaryocyte maturation, the approach improves yield, shortens production time, and lowers culture cost.

• circRHOBTB3–NONO Axis in Metastatic Prostate Cancer

  2026-08-20

  The reference study identifies circRHOBTB3 as a tumor-suppressive circular RNA that restrains prostate cancer progression by retaining NONO in the cytoplasm and reducing MAOA transcription. Its integrated analysis of circRNA expression, RNA–protein localization, transcriptional control, and metastatic models provides a mechanistic framework for studying metastatic prostate cancer biology.

• Ferroptosis Inducers in Advanced Prostate Cancer

  2026-08-19

  Ghoochani and colleagues show that treatment-resistant prostate cancer remains vulnerable to ferroptosis induction by erastin and RSL3, both in cell-based models and tumor-bearing models. The study also identifies a rationale for combining ferroptosis inducers with second-generation anti-androgens, while highlighting the need for biomarker-guided validation before clinical translation.

• Neuromedin S (rat): GPCR Assay Guide

  2026-08-19

  Neuromedin S (rat) provides a defined rat peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein signaling workflows. It is suitable for laboratory assay development and pathway analysis, but not for diagnostic, therapeutic, clinical, or unvalidated cross-species use.

• Sodium Ascorbate: Reproducible Cell Assay Workflows

  2026-08-18

  A scenario-driven guide to using Sodium Ascorbate, SKU B1834, in cell viability, proliferation, cytotoxicity, and glioblastoma multiforme research. It covers solvent compatibility, ROS-linked interpretation, protocol controls, and practical vendor-selection criteria.

• Praeruptorin A: Applied Workflow Guide

  2026-08-18

  Praeruptorin A is an angular pyranocoumarin compound suited to mechanism-led studies spanning ferroptosis, inflammatory barrier injury, cardiomyopathy research, and tumor cell invasion. This practical guide shows how to build concentration-response workflows, pair early signaling with late functional readouts, and troubleshoot solubility, vehicle, and assay-timing problems.

• Mechanisms of Cell Death in Heart Disease: Key Insights

  2026-08-17

  The reference review reframes cardiac injury by showing that apoptosis and necrosis are distinct morphologic outcomes connected through overlapping, regulated signaling networks. Its most important contribution is the recognition that a substantial subset of necrotic death is actively controlled, creating a rationale for mechanism-specific cell-death intervention in myocardial infarction and heart failure.

• Sunitinib B1045 for Reliable Cancer Assays

  2026-08-17

  A scenario-based guide to using Sunitinib (SKU B1045) in cell viability, proliferation, apoptosis, and resistance studies. It connects documented formulation and handling parameters with practical assay controls and recent evidence from renal cell carcinoma research.

• HATU to Translational Inhibitor Design

  2026-08-16

  How HATU-enabled peptide synthesis chemistry can support structure-guided IRAP inhibitor discovery, from carboxylic acid activation and stereochemical control to translational validation.

• Clozapine N-oxide for DREADD Circuit Studies

  2026-08-15

  Clozapine N-oxide enables reversible, receptor-defined neuronal activity modulation for circuit mapping, behavioral causality, and GPCR signaling research. This practical guide connects CNO workflows to a newly defined visual cortical–entorhinal pathway while emphasizing controls, solubility management, and assay-specific troubleshooting.

• EdU Imaging Kits (HF594) for Resistance Studies

  2026-08-14

  EdU Imaging Kits (HF594) convert S-phase DNA synthesis into a sensitive fluorescence readout for drug-resistance, genotoxicity, and pharmacodynamic studies. Their click-chemistry workflow supports both microscopy and flow cytometry while avoiding the DNA-denaturation step required by traditional BrdU assays.

7980 records 1/532 page Next 12345 下5页 Last page